Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sildenafil for Fontan Associated Liver Disease (SiFALD) Study

NCT03154476 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT03154476
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03154476 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sildenafil for Fontan Associated Liver Disease (SiFALD) Study
Lead sponsor
Mayo Clinic
Phase
Phase 3
Overall status
Completed
Start date
July 5, 2017
Completion date
June 30, 2019
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cirrhosis, congenital heart disease